Serum Institute of India (SII) is expanding its vaccine business in the United Kingdom with an investment of £240 million. The serum has already started phase one trials in the UK of a one-dose nasal vaccine for coronavirus, in partnership with Codagenix INC. This was a part of the £533 million of new Indian investment in the UK in growing sectors such as health and technology.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
Serum’s investment will support clinical trials, research & development and possibly manufacturing of vaccines. This will help the UK and the world to defeat the coronavirus pandemic and other deadly diseases.
Important takeaways for all competitive exams:
India has delivered the strong performance at the ISSF Junior World Cup 2026 in the…
Sun Pharmaceutical Industries Limited, commonly known as Sun Pharma, is the largest pharmaceutical company in…
Sabastian Sawe has achieved the historical achievement as he completed the an official marathon in…
Andhra Pradesh state government has announced the first Mushroom Mission with the investment around the…
The Delhi Metro Rail Corporation (DMRC) has appointed Mr. Sanjay Jamuar as the first Chief…
The French President Emmanuel Macron has said that he will step away from the politics…